David C. Marek - 18 Jan 2023 Form 4 Insider Report for Myovant Sciences Ltd.

Role
Principal Executive Officer, Director
Signature
/s/ Matthew Lang, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
18 Jan 2023
Net transactions value
-$216,115
Form type
4
Filing time
20 Jan 2023, 15:34:02 UTC
Previous filing
20 Oct 2022
Next filing
10 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYOV Common Shares Sale $216,115 -8,037 -1.9% $26.89 417,599 18 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.